Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.0%

3 terminated out of 30 trials

Success Rate

85.0%

-1.5% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results85% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (11)
P 1 (7)
P 2 (4)
P 3 (2)

Trial Status

Completed17
Unknown5
Terminated3
Recruiting2
Active Not Recruiting2
Withdrawn1

Trial Success Rate

85.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT06356272Recruiting

Oropharynx (OPX) Biomarker Trial

NCT03757091Not ApplicableCompletedPrimary

Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery

NCT04099290RecruitingPrimary

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT04477759Phase 1CompletedPrimary

Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer

NCT03840421Phase 3Active Not Recruiting

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT04005521Not ApplicableActive Not RecruitingPrimary

Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients with Head and Neck Cancer

NCT05183243Phase 1Unknown

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

NCT03012581Phase 2Completed

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

NCT03418480Phase 1Completed

HARE-40: HPV Anti-CD40 RNA vaccinE

NCT02960308CompletedPrimary

Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors

NCT04086849CompletedPrimary

Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers

NCT03837808Phase 3Unknown

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

NCT05590650Phase 1CompletedPrimary

A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients

NCT03854838Phase 2Unknown

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

NCT04679233Not ApplicableWithdrawnPrimary

Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients

NCT04277273Not ApplicableCompletedPrimary

Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris

NCT04151030Not ApplicableCompletedPrimary

Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure

NCT05011500Not ApplicableUnknownPrimary

Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)

NCT03402737Not ApplicableTerminatedPrimary

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

NCT03151889Not ApplicableCompleted

Eletric Stimulation for Hipossalivation Induced by Radiotherapy

Scroll to load more

Research Network

Activity Timeline